Skip to main content
. 2022 Dec 29;2022:7745315. doi: 10.1155/2022/7745315

Table 2.

Univariate and multivariate survival analyses of clinicopathological variables of HCC patients.

Characteristics Overall survival
Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
CCDC45 expression 14.635 (4.424-48.412) <0.001 11.413 (3.402-38.285) <0.001
 Low vs. high
Age (years) 1.318 (0.352-1.476) 0.371
  ≤50 vs. >50
Gender 0.536 (0.128-2.249) 0.394
 Male vs. female
AJCC stage 2.469 (1.197-5.092) 0.014 1.655 (0.790-3.466) 0.182
 I vs. II-III
HBsAg 0.692 (0.265-1.806) 0.452
 Negative vs. positive
AFP (ng/ml) 1.182 (0.574-2.436) 0.650
  ≤ 400 vs. >400
Total bilirubin (μmol/L) 0.930 (0.357-2.424) 0.882
  ≤20 vs. >20
ALT (U/L) 0.867 (0.408-1.812) 0.711
  ≤ 45 vs. >45
GGT (U/L) 0.401 (0.164-0.977) 0.044 0.470 (0.184-1.203) 0.115
  ≤ 40 vs. >40
Edmondson-Steiner grade 4.985 (2.274-10.928) < 0.001 3.335 (1.497-7.428) 0.003
 I-II vs. III-IV
Tumor number 1.887 (0.771-4.621) 0.165
 Single vs. multiple
Tumor size (cm) 2.103 (1.033-4.281) 0.041 1.183 (0.560-2.502) 0.660
  ≤ 5 vs. >5